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Abstract 
A reference monoclonal antibody IgG1 and a fusion IgG protein were analyzed by top- and 
middle-down mass spectrometry with multiple fragmentation techniques including electron 
transfer dissociation (ETD) and matrix-assisted laser desorption ionization in-source decay 
(MALDI-ISD) to investigate heterogeneity of glycosylated protein species. Specifically, glycan 
structure, sites, relative abundance levels, and termini structural conformation were investigated 
by use of Fourier transform ion cyclotron resonance (FT-ICR) or high performance liquid 
chromatography electrospray ionization (HPLC-ESI) linked to an Orbitrap. Incorporating a 
limited enzymatic digestion by immunoglobulin G-degrading enzyme Streptococcus pyogenes 
(IdeS) with MALDI-ISD analysis extended sequence coverage of the internal region of the 
proteins without pre-fractionation. The data in this article is associated with the research article 
published in Journal of Proteomics [1]. 
 
 
Specifications Table  
Subject area Biology, Chemistry 
More specific subject 
area 
Top- and middle-down mass spectrometric analysis of protein species 
and proteoforms 
Type of data Table, Figure 
How data was acquired Mass spectrometry data were collected on a 12T FT-ICR XR 
(Bruker) and a LTQ-Orbitrap Elite (Thermo Scientific). 
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Data format MS spectra 
Experimental factors Top- and middle-down analyses with multiple fragmentation 
techniques including electron transfer dissociation (ETD) and matrix-
assisted laser desorption ionization in-source decay (MALDI-ISD) 
for characterization of a reference monoclonal antibody IgG1 and a 
fusion IgG protein. 
Experimental features Glycan profiling including structure, sites, relative abundance levels, 
and termini structural conformation were investigated 
Data source location Baltimore and Gaithersburg, Maryland, USA 
Data accessibility Data is provided within this article. 
 
 
Value of the data  
 Application of top-down and middle-down mass spectrometry for characterization of 
comprehensive glycosylated protein species from recombinant IgG and IgG-fusion 
proteins. 
 Detection of glycan structure, sites, and relative abundance levels. 
 Investigation of termini structural conformation; N-terminal glutamine (Q) to 
pyroglutamate (pyroGlu, aka. pE) conversion and C-terminal lysine truncation. 
 Improvement on protein sequencing by MALDI ISD, ETD in combination with middle-








Experimental Design, Materials and Methods 
The recombinant human mAb (IgG1) and IgG1-fusion protein were manufactured using standard 
cell culture, purification and formulation processes [2]. The IgG1 has two identical light chains 
and two identical heavy chains with molecular weight of 150KDa and N-glycosylation site at 
N297. The IgG fusion protein, approximately 90kDa, was comprised of two chains each with a 
human protein domain fused onto the N-terminus of a human IgG1 constant domain (Fc). The 
protein has three N-glycosylation sites at N76, N108 and N207. 
 
1. Analysis of the IgG protein 
The IgG protein was analyzed 1) in reduced form by MALDI-ISD in a 12 Tesla Fourier 
Transform Ion Cyclotron Resonance (FT-ICR XR) mass spectrometer (Bruker, Bremen, 
Germany), and 2) after IdeS digestion and dithiothreitol (DTT) reduction to generate three 
 3 
smaller fragments; light chain, Fab, and Fc/2 after which analyzed by LC-MS/MS on an Orbitrap 
Elite (Thermo Scientific, Saint Jose, CA, USA).  
 
1.1. MALDI-ISD analysis of reduced protein 
The IgG protein in 1µg/µL in 50mM ammonium bicarbonate buffer was reduced to light and 
heavy chain by 20mM dithiothreitol (DTT, product #43815, Sigma-Aldrich, St. Louis, MO, 
USA) at 80oC for 15min. The reduced protein sample was buffer exchanged to 5% acetonitrile 
(ACN) /0.1% formic acid (FA) using a 10kDa molecular weight cut off (MWCO) centrifugal 
filter (product # UFC201024, Merck Millipore, Tullagreen, Carrigtwohill, Ireland) and then 
diluted to 17 µg/µL in 50% ACN/0.1% FA. One µL sample and 1 µL of 1,5-diaminonaphthalene 
(1,5-DAN, product # 56451, Fluka, St. Louis, MO, USA) saturated in ACN were spotted on a 
stainless steel MALDI plate. MALDI-ISD experiment was performed with a transient domain of 
1 mega-word data points (estimated resolving power of 270,000 at m/z 400) covering m/z range 
400-10,000. MALDI-ISD mass spectra after phase correction [3] were processed to identify c- 
and z+2 ions from light chain and heavy chain with mass tolerance 50 ppm using DataAnalysis 
4.2 and Biotools software 3.2 (Bruker) (Figure 1). 
 
1.2. LC-MS/MS analysis of IdeS-digested protein 
The IgG protein was digested with IdeS (product # A0-FR1-020, Genovis AB, Lund, Sweden) at 
a ratio of 1 unit of enzyme per 1µg protein for 2 hours at 37oC, followed by DTT treatment. 
Approximately 14 µg of the IdeS/DTT treated sample was separated on a 100 µm x 20 mm 
column packed with Jupiter 5 µm C5 particles (product # 04A-4052, Phenomenex, Torrance, 
CA, USA) by a fast mobile gradient of 5% to 50% ACN/0.1% FA in 15 min at a flow rate of 0.3 
µL/min. Light chain and Fd domain were detected in a range of 350-3500 m/z at resolving power 
of 120,000 in positive ion mode on the Orbitrap Elite (Figure 2). Precursor masses were selected 
for ETD fragmentation. ETD spectra were acquired with 5 microscans at resolving power of 
120,000 and processed by MASH Suite version 1.0 software [4]. The fragment ions and 
corresponding sequence coverage are shown in Figure 3A for the light chain and Figure 3B for 
the Fd domain. Glutamine (Q) to pyroglutamate (pyroGlu) conversion was confirmed on the N-
terminal of heavy chain (Figure 3B).  
 
2. Analysis of the IgG fusion protein 
The fusion protein was analyzed 1) by accurate mass measured in FT-ICR for protein species 
detection 2) by MALDI-ISD following DTT reduction in FT-ICR, and 3) by accurate mass 
measurement following IdeS cleavage in FT-ICR or ETD MS/MS in the Orbitrap Elite. 
 
2.1 Accurate mass measurement of intact protein 
The fusion protein sample was buffer exchanged to 5%ACN and 0.1%TFA using Amicon 50kDa 
MWCO centrifugal filters (product # UFC505024, Merck Millipore). Since the fusion protein 
sample was stored in buffer with detergent, detergent removal was performed by Pierce detergent 
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removal kit (product # 87778, Thermo Scientific, Rockford, CA, USA). The detergent-free 
protein sample was diluted to 10 µg/µL final concentration in 50% ACN/0.1% FA and 
introduced to electrospray ionization (ESI)-FT-ICR for intact protein mass measurement for 
detection of protein species. The experiment was carried out in positive ion mode on the 12 T 
FT-ICR at flow rate 2µL/min. Mass spectra were collected in magnitude mode with a transient 
domain of 128,000 word data points to cover m/z range 400 – 4000, with an accumulation of 
1650 scans. Figure 4 shows the protein species detected in m/z region 2365 – 2450 with high 
heterogeneity of glycosylation. Corresponding glycan nomenclature and structures are shown in 
Figure 5. 
 
2.2 MALDI-ISD analysis of reduced protein 
The protein sample was diluted to 1 µg/µL in in 50mM ammonium bicarbonate buffer and 
reduced with 20mM DTT at 80oC for 15min. The reduced sample was then detergent removed. 
The detergent-free protein was diluted in 50% ACN/0.1% FA at a final concentration of 7 
µg/µL. One µL of sample and 1 µL of DAN matrix were spotted on stainless steel MALDI plate. 
MALDI-ISD mass spectra were recorded for m/z range 400-10,000 with a transient domain of 1 
mega-word data points and estimated resolving power of 270,000 (at m/z 400). MALDI-ISD 
spectra were phased corrected and processed using DataAnalysis and Biotools software. 
Fragment ions were identified with mass tolerance 50 ppm and sequence coverage of the fusion 
protein is shown in Figure 6. 
 
2.3 ETD MS/MS analysis of IdeS-digested protein 
The fusion protein sample was diluted to 1 µg/µL in 50mM ammonium bicarbonate solution and 
digested with enzyme IdeS at ratio of 1 enzyme unit to 1 µg protein for 2 hours at 37oC. 20mM 
DDT was added to cleave disulfide bonds at 80oC for 15min. The sample was further 
concentrated using 10kDa MWCO filter and subject to detergent removal. The sample buffer 
was exchanged to 5% ACN/0.1% FA and diluted to final concentration of approximately 7 
µg/µL in 50 %ACN/0.1% FA. IdeS digestion and DTT reduction cut the fusion protein to half 
the size producing N-terminal and C-terminal fragments. 
 
Accurate mass measurement of the IdeS/DTT treated sample was performed by ESI FT-ICR. 
Mass spectra were collected in magnitude mode with a transient domain of one mega-word data 
points to cover m/z range 400 – 4000. Seven glycoforms were identified from the C-terminus at 
multiple charge states. Table 1 represents glycosylated protein species detected from 17+ charge 




















G0 1479.64124 17+ 25137.77353 25139.397044 -1.62 -64.58 
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G0f 1488.28997 17+ 25284.83767 25282.454953 2.38 94.24 
G1f 1497.76750 17+ 25445.88614 25444.507776 1.38 54.17 
G2f 1507.29477 17+ 25607.90766 25606.560599 1.35 52.61 
G1f+NANA 1514.88175 17+ 25736.94787 25735.063193 1.88 73.23 
G2f+NANA 1524.41738 17+ 25899.02107 25897.656016 1.37 52.71 
G2f+NANA2 1541.54188 17+ 26190.11349 26188.751433 1.36 52.01 
Table 1. Glycosylated protein species detected by Fourier transform ion cyclotron resonance 
(FT-ICR) accurate mass measurement of DTT/IdeS treated fusion protein from the 17+ charge 
state. Highlighted in bold are the most abundance glycoforms detected on the C-terminal 
fragment of the protein. Additional information regarding the glycan nomenclature and structure 
are provided in the Figure 6. 
 
The sample was also directly infused into the Orbitrap Elite. Data were collected in positive ion 
mode for 350-3500 m/z range at resolving power of 120,000 (Figure 7). Precursor masses of the 
glycoforms were isolated for ETD fragmentation. ETD mass spectra were acquired with 5 
microscans at resolving power of 120,000 and processed by MASH Suite for sequence coverage 
analysis. Manual interpretation of the ETD spectra confirmed that glycosylation by G0f or G1f 
occurred on a site N207 and the protein has a C-terminal lysine truncation (Figure 8).  
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